The Genomic, Transcriptomic, and Immunological Landscape of Sodium-glucose cotrasporter 2 in Lung Cancer and Association with Clinical Outcomes | Caris Life Sciences
Portal
Order
Home / Research / Publications / The Genomic, Transcriptomic, and Immunological Landscape of Sodium-glucose cotrasporter 2 in Lung Cancer and Association with Clinical Outcomes

Publications

Back

The Genomic, Transcriptomic, and Immunological Landscape of Sodium-glucose cotrasporter 2 in Lung Cancer and Association with Clinical Outcomes

– Caris Life Sciences

Poster

Conclusions

  • SLC5A2 expression was associated with a highly altered genomic landscape in AC
  • In specific subgroups, high expression of SLC5A2 was associated with OS and TOT with immunotherapy
Download Publication

Discover
More

  • The genomic, transcriptomic, and immunologic landscape in solid tumors expressing leukocyte immunoglobulin like receptor B2

    – Caris Life Sciences

    Poster

    Study Highlights The genomic landscape of high versus low LILRB2 expressors varied widely by cancer type. LILRB2 expression was associated with biomarkers of response to… […]

  • The Genomic, Transcriptomic, and Immunological Landscape of TROP2 in Solid Tumors

    – Caris Life Sciences

    Poster

    Study Highlights The genomic landscape of high versus low TACSTD2 expressors varied widely by cancer type. Significant but small difference in TACSTD2 expression was observed… […]
Learn More

Ready to Get Started on the Journey?

Name(Required)